(2) | Represents (i) 209,613 shares of common stock, par value $0.0001 per share (the “Common Stock”) issued upon the conversion of shares of Series C Preferred Stock, par value $0.0001 per share, to investors that participated in certain in private placements; (ii) 461,372 shares of Common Stock previously issued by the Company to certain shareholders after February 6, 2024, the effectiveness date of the Registration Statement on Form S-4, filed in connection with that certain Agreement and Plan of Merger, dated as of November 15, 2023 (as amended, the “Merger Agreement” and the transactions contemplated thereunder and consummated on August 12, 2024, the “Merger”); (iii) 319,207 shares of Common Stock issued to the investors in a private placement transaction, pursuant to that certain Securities Purchase Agreement, dated as of July 26, 2024, by and among the Company and each of the purchasers thereto; (iv) 504,323 shares of Common Stock issuable upon the exercise of certain pre-funded warrants; (v) 823,530 shares of Common Stock issuable upon the exercise of certain warrants; (v) 168,071 shares of Common Stock issuable upon the exercise of the Series C Warrants; (vi) 61,866 shares of Common Stock issuable upon the exercise of certain Series D Warrants; and (vii) 11,663 shares of Common Stock issuable upon the exercise of warrants issued to certain brokers as compensation in connection with certain transactions. |